Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic

Thuy D Nguyen; Sumedha Gupta; Engy Ziedan; Kosali I Simon; G Caleb Alexander; Brendan Saloner; Bradley D Stein

doi:10.1001/jamainternmed.2020.7497

Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic

JAMA Intern Med. 2021 Apr 1;181(4):562-565. doi: 10.1001/jamainternmed.2020.7497.

Authors

Thuy D Nguyen¹, Sumedha Gupta², Engy Ziedan³, Kosali I Simon⁴, G Caleb Alexander⁵, Brendan Saloner⁶, Bradley D Stein⁷

Affiliations

¹ Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor.
² Department of Economics, Indiana University-Purdue University Indianapolis.
³ Department of Economics, Tulane University, New Orleans, Louisiana.
⁴ O'Neill School Public and Environmental Affairs, Indiana University Bloomington.
⁵ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁶ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁷ RAND Corporation, Pittsburgh, Pennsylvania.

Abstract

This cohort study examines changes in the number of buprenorphine prescriptions fill by individuals with opioid use disorder before and during the coronavirus disease 2019 pandemic.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Buprenorphine / therapeutic use*
COVID-19 / epidemiology*
Drug Prescriptions / statistics & numerical data*
Humans
Narcotic Antagonists / therapeutic use*
Opioid-Related Disorders / drug therapy*
Practice Patterns, Physicians' / statistics & numerical data*

Substances

Narcotic Antagonists
Buprenorphine

Grants and funding

R01 DA045800/DA/NIDA NIH HHS/United States